Sponsor

Seoul National University Bundang Hospital

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Seoul National University Bundang Hospital appears in 130 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials130
Recruiting shown14
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 DiabetesNCT07719894 · lead sponsor · 2026-05-06
RECRUITING
Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis StemNCT07828080 · lead sponsor · 2025-06-18
RECRUITING
SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary ResectionNCT07102589 · lead sponsor · 2025-06-01
RECRUITING
Cilostazol-Ginkgo for Cognitive Function in Elderly DiabetesNCT06989697 · lead sponsor · 2025-01-01
RECRUITING
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 DiabetesNCT06989723 · lead sponsor · 2025-01-01
RECRUITING
Clopidogrel Versus Cilostazol on VesselsNCT06402747 · lead sponsor · 2024-04-16
RECRUITING
Enavogliflozin vs. Pioglitazone on Glucose and AtherosclerosisNCT06399835 · lead sponsor · 2024-02-01
RECRUITING
The EMPA-FIT StudyNCT06846411 · lead sponsor · 2024-01-01
RECRUITING
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaNCT05365425 · lead sponsor · 2023-06-01
RECRUITING
Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung LesionsNCT05804786 · lead sponsor · 2023-04-01
RECRUITING
Dual-chamber Patient-controlled Analgesia for Postoperative RecoveryNCT07051109 · lead sponsor · 2022-10-11
RECRUITING
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaNCT05365438 · lead sponsor · 2022-10-01
RECRUITING
Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled TrialNCT05211375 · lead sponsor · 2022-01-03
RECRUITING
Korean Heart Failure Registry IIINCT04329234 · lead sponsor · 2018-10-01
RECRUITING
Effectiveness of Video-Based Movement Analysis-Guided Personalized Rehabilitation in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)NCT07714278 · lead sponsor · 2026-06-30
ENROLLING_BY_INVITATION
Effect of Positive End-expiratory Pressure on the Gastric VolumeNCT06861569 · lead sponsor · 2025-03-15
UNKNOWN
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DNCT05140694 · lead sponsor · 2023-12-01
UNKNOWN
Remimazolam vs Propofol as an Induction Agent for Morbid Obesity PatientsNCT05856617 · lead sponsor · 2022-10-25
UNKNOWN
Mobile App for Heart FailureNCT05668000 · lead sponsor · 2022-10-19
COMPLETED
Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy PatientsNCT05253170 · lead sponsor · 2022-04-01
NOT_YET_RECRUITING
Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and SafetyNCT05915949 · lead sponsor · 2022-01-01
UNKNOWN
Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation BronchoscopyNCT05110131 · lead sponsor · 2021-12-01
UNKNOWN
Carvedilol in HF With Preserved EFNCT05553314 · lead sponsor · 2021-11-17
COMPLETED
Vagus Nerve Preservation and Chronic Cough in Non-small Cell Lung Cancer SurgeryNCT04923412 · lead sponsor · 2021-07-01
UNKNOWN
Needle Radiofrequency Treatment for Submental FatNCT05517824 · lead sponsor · 2021-06-07
COMPLETED
ERAS After Bariatric Surgery in Morbidly ObeseNCT04891822 · lead sponsor · 2021-06-02
COMPLETED
Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and HypertensionNCT05189015 · lead sponsor · 2021-01-01
COMPLETED
The Development of Quantitative Ultrasound Imaging Software PlatformNCT05836246 · lead sponsor · 2020-09-01
UNKNOWN
Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 DiabetesNCT05663736 · lead sponsor · 2020-01-01
UNKNOWN
Mobile App for BP ControlNCT04470284 · lead sponsor · 2019-09-01
COMPLETED
Effect of Empagliflozin on Body Composition and KetonesNCT03877406 · lead sponsor · 2018-08-01
UNKNOWN
Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and HypertensionNCT05173025 · lead sponsor · 2018-01-01
UNKNOWN
Effects on the Personalized Rehabilitation Service in Patients With CancerNCT03200067 · lead sponsor · 2017-06-03
UNKNOWN
Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and MetforminNCT03076112 · lead sponsor · 2017-04-25
COMPLETED
Effect of Aging & Obesity With Exercise InterventionNCT03951857 · lead sponsor · 2016-11-18
COMPLETED
Immediate Release Versus Slow Release Carvedilol in Heart FailureNCT03209180 · lead sponsor · 2016-10-27
UNKNOWN
Effectiveness of Nefopam in Breast Cancer SurgeryNCT02949310 · lead sponsor · 2016-10-01
UNKNOWN
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 DiabetesNCT03248401 · lead sponsor · 2016-09-26
COMPLETED
Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic SignificanceNCT03024476 · lead sponsor · 2016-09-01
COMPLETED
Korean OBEsity Surgical Treatment StudyNCT03100292 · lead sponsor · 2016-09-01
UNKNOWN
Investigation of Anti-obesity Properties of Lactobacillus Sakei in Obese Human SubjectsNCT03248414 · lead sponsor · 2016-08-10
COMPLETED
Therapeutic Efficacy of Categorical Language Fluency Smartphone Game ApplicationNCT02848404 · lead sponsor · 2016-06-01
COMPLETED
The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With DiabetesNCT03249259 · lead sponsor · 2016-03-10
COMPLETED
Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure ManagementNCT02673073 · lead sponsor · 2016-01-01
UNKNOWN
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in HypertensionNCT03226340 · lead sponsor · 2015-12-02
UNKNOWN
Development of Personalized Health Care Service in Patients With Breast CancerNCT03194399 · lead sponsor · 2015-11-27
COMPLETED
Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to GliclazideNCT02610088 · lead sponsor · 2015-11-01
COMPLETED
Initial Combination of Gemigliptin and Metformin on Microbiota ChangeNCT02609815 · lead sponsor · 2015-11-01
COMPLETED
Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer PatientsNCT03067012 · lead sponsor · 2015-09-01
COMPLETED
A Prospective Cohort Study of Aged People for Chronic DiseasesNCT02640872 · lead sponsor · 2015-07-01
COMPLETED
The Preemptive Analgesic Efficacy of NefopamNCT02561468 · lead sponsor · 2015-04-01
COMPLETED
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination TherapyNCT02338921 · lead sponsor · 2015-01-01
COMPLETED
Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 DiabetesNCT02185963 · lead sponsor · 2014-10-01
COMPLETED
Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes ManagementNCT02315287 · lead sponsor · 2014-09-01
UNKNOWN
Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic PatientsNCT02188186 · lead sponsor · 2014-07-01
COMPLETED
Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood PressureNCT03255551 · lead sponsor · 2014-01-01
COMPLETED
Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes CareNCT02025296 · lead sponsor · 2013-12-01
COMPLETED
Efficacy and Safety of Voice Inception Technique Based U-healthcare Service in Patients With Type 2 Diabetes MellitusNCT01891474 · lead sponsor · 2013-08-01
COMPLETED
Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive DisorderNCT01997580 · lead sponsor · 2013-07-01
UNKNOWN
The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular RiskNCT01972542 · lead sponsor · 2013-06-01
COMPLETED

Drugs studied in this sponsor's trials

43 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Seoul National University Bundang Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

glimepiride RxCUI 25789 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial glycerylphosphorylcholine RxCUI 4918 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ibandronate Oral Tablet RxCUI 452852 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial iloprost RxCUI 40138 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial lapatinib RxCUI 480167 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial magnesium sulfate RxCUI 6585 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial nivolumab RxCUI 1597876 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial olmesartan RxCUI 321064 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial phenylephrine RxCUI 8163 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial pioglitazone 15 MG [Actos] RxCUI 574495 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial policosanol RxCUI 69440 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial prednisolone RxCUI 8638 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial remimazolam besylate RxCUI 2383942 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial rosuvastatin RxCUI 301542 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial sacubitril / valsartan RxCUI 1656339 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial Tagrisso RxCUI 1721566 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial valsartan RxCUI 69749 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial vildagliptin RxCUI 596554 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial vinorelbine RxCUI 39541 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor84
collaborator46
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.